I-Mab Biopharma
IMAB
#9469
Rank
โ‚ฌ50.55 M
Marketcap
0,62ย โ‚ฌ
Share price
-6.87%
Change (1 day)
-63.23%
Change (1 year)

I-Mab Biopharma (IMAB) - Cash on Hand

Cash on Hand as of September 2024 : โ‚ฌ0.16 Billion

According to I-Mab Biopharma's latest financial reports the company has โ‚ฌ0.16 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

I-Mab Biopharma - Cash on Hand chart (from 2024 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚ฌ41.24 M-38.97%
2022-12-31โ‚ฌ67.58 M-27.32%
2021-12-31โ‚ฌ92.97 M1.73%
2020-12-31โ‚ฌ91.39 M327.92%
2019-12-31โ‚ฌ21.35 M-37.32%
2018-12-31โ‚ฌ34.07 M202.45%
2017-12-31โ‚ฌ11.26 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚ฌ14.95 M-91.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.39 B 134.25%๐Ÿ‡บ๐Ÿ‡ธ USA